Klin Padiatr 2018; 230(06): 340
DOI: 10.1055/s-0038-1675275
Georg Thieme Verlag KG Stuttgart · New York
Treatment of human glioblastoma cells with the Chk1 inhibitor SAR-020106 and irradiation and/or 5-aza-2'deoxycytidine synergistically reduces clonogenic survival
I Patties
1
Department of Radiation Oncology, University of Leipzig, Leipzig, Germany
,
L Thöle
1
Department of Radiation Oncology, University of Leipzig, Leipzig, Germany
,
F Gaunitz
2
Department of Neurosurgery, University of Leipzig, Leipzig, Germany
,
RD Kortmann
1
Department of Radiation Oncology, University of Leipzig, Leipzig, Germany
,
A Glasow
1
Department of Radiation Oncology, University of Leipzig, Leipzig, Germany
› Author Affiliations
